• Something wrong with this record ?

Chlorinated plastoquinone analogs that inhibit Staphylococcus epidermidis and Candida albicans growth

EM. Kara, N. Bayrak, H. Yıldırım, M. Yıldız, BO. Celik, AF. Tuyun

. 2020 ; 65 (5) : 785-795. [pub] 20200526

Language English Country United States

Document type Journal Article

Grant support
FBA-2016-20662 the Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa

Infectious diseases are the significant global health problem because of drug resistance to most classes of antimicrobials. Interest is growing in the development of new antimicrobials in pharmaceutical discovery. For that reason, the urgency for scientists to find and/or develop new important molecules is needed. Many natural active molecules that exhibit various biological activities have been isolated from the nature. For the present research, a new selected set of aminobenzoquinones, denoted as plastoquinone analogs (PQ1-24), was employed for their in vitro antimicrobial potential in a panel of seven bacterial strains (three Gram-positive and four Gram-negative bacteria) and three fungi. The results revealed PQ analogs with specific activity against bacteria including Staphylococcus epidermidis and pathogenic fungi, including Candida albicans. PQ8 containing methoxy group at the ortho position on the phenylamino moiety exhibited the highest growth inhibition against S. epidermidis with a minimum inhibitory concentration of 9.76 μg/mL. The antifungal profile of all PQ analogs indicated that five analogs (while PQ1, PQ8, PQ9, PQ11, and PQ18 were effective against Candida albicans, PQ1 and PQ18 were effective against Candida tropicalis) have potent antifungal activity. Selected analogs, PQ1 and PQ18, were studied for biofilm evaluation and time-kill kinetic study for better understanding.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011255
003      
CZ-PrNML
005      
20210420110142.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-020-00783-8 $2 doi
035    __
$a (PubMed)32458315
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kara, Emel Mataracı $u Pharmaceutical Microbiology Department, Pharmacy Faculty, Istanbul University, Beyazit, 34116, Istanbul, Turkey. emataraci@istanbul.edu.tr
245    10
$a Chlorinated plastoquinone analogs that inhibit Staphylococcus epidermidis and Candida albicans growth / $c EM. Kara, N. Bayrak, H. Yıldırım, M. Yıldız, BO. Celik, AF. Tuyun
520    9_
$a Infectious diseases are the significant global health problem because of drug resistance to most classes of antimicrobials. Interest is growing in the development of new antimicrobials in pharmaceutical discovery. For that reason, the urgency for scientists to find and/or develop new important molecules is needed. Many natural active molecules that exhibit various biological activities have been isolated from the nature. For the present research, a new selected set of aminobenzoquinones, denoted as plastoquinone analogs (PQ1-24), was employed for their in vitro antimicrobial potential in a panel of seven bacterial strains (three Gram-positive and four Gram-negative bacteria) and three fungi. The results revealed PQ analogs with specific activity against bacteria including Staphylococcus epidermidis and pathogenic fungi, including Candida albicans. PQ8 containing methoxy group at the ortho position on the phenylamino moiety exhibited the highest growth inhibition against S. epidermidis with a minimum inhibitory concentration of 9.76 μg/mL. The antifungal profile of all PQ analogs indicated that five analogs (while PQ1, PQ8, PQ9, PQ11, and PQ18 were effective against Candida albicans, PQ1 and PQ18 were effective against Candida tropicalis) have potent antifungal activity. Selected analogs, PQ1 and PQ18, were studied for biofilm evaluation and time-kill kinetic study for better understanding.
650    _2
$a antiinfekční látky $x chemie $x farmakologie $7 D000890
650    _2
$a biofilmy $x účinky léků $x růst a vývoj $7 D018441
650    _2
$a Candida albicans $x účinky léků $x růst a vývoj $7 D002176
650    _2
$a halogenace $7 D054879
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a molekulární struktura $7 D015394
650    _2
$a plastochinon $x analogy a deriváty $x chemie $x farmakologie $7 D010971
650    _2
$a Staphylococcus epidermidis $x účinky léků $x růst a vývoj $7 D013212
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bayrak, Nilüfer $u Chemistry Department, Engineering Faculty, Istanbul University-Cerrahpasa, Avcilar, 34320, Istanbul, Turkey
700    1_
$a Yıldırım, Hatice $u Chemistry Department, Engineering Faculty, Istanbul University-Cerrahpasa, Avcilar, 34320, Istanbul, Turkey
700    1_
$a Yıldız, Mahmut $u Chemistry Department, Gebze Technical University, Gebze, 41400, Kocaeli, Turkey
700    1_
$a Celik, Berna Ozbek $u Pharmaceutical Microbiology Department, Pharmacy Faculty, Istanbul University, Beyazit, 34116, Istanbul, Turkey
700    1_
$a Tuyun, Amaç Fatih $u Department of Chemistry, Faculty of Science, Istanbul University, Vezneciler, 34134, Istanbul, Turkey. aftuyun@gmail.com
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 5 (2020), s. 785-795
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32458315 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210420110138 $b ABA008
999    __
$a ok $b bmc $g 1643920 $s 1131634
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 65 $c 5 $d 785-795 $e 20200526 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a FBA-2016-20662 $p the Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...